The TCGA program subsequently undertook a multiplatform characterization of cutaneous melanoma samples at the DNA, RNA, and protein levels, in which NF1-mutant melanoma emerged as an important subtype within a genomic classification framework [2]. The gene discussed is NF1; the disease is melanoma.